Ex-Dermavant Exec Jassie Joins eGenesis as Chief Business Officer

Xconomy Boston — 

Ariel Jassie has been appointed chief business officer and general counsel of eGenesis. Jassie most recently worked at Dermavant Sciences, where he was chief business and strategy officer. His experience also includes posts at Codiak Biosciences and Celgene (NASDAQ: CELG). Cambridge, MA-based eGenesis is researching applications of the CRISPR gene-editing technology to make pig organs suitable for transplant into humans.